Literature DB >> 12409719

Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.

Manuela Pelmus1, Louis Guillou, Isabelle Hostein, Ghislaine Sierankowski, Catherine Lussan, Jean-Michel Coindre.   

Abstract

Diagnosing monophasic fibrous and poorly differentiated synovial sarcoma (SS) on morphology alone is often a source of problems for pathologists. SS bear the t(X;18)(p11.2,q11.2) translocation, which proved to be specific for this tumor type and is currently considered one of the most reliable diagnostic criteria. To evaluate the sensitivity of immunohistochemical techniques in diagnosing monophasic fibrous SS (MFSS) and poorly differentiated SS (PDSS), we examined 60 t(X;18)(SYT-SSX)-positive cases (47 MFSS and 13 PDSS) for cytokeratin AE1/AE3, cytokeratin KL1, epithelial membrane antigen, E-cadherin, CD34, S-100 protein, alpha-smooth muscle actin, desmin, h-caldesmon, CD99, bcl2, and C-kit (CD117) antibodies. Of the four epithelial markers tested, epithelial membrane antigen proved to be the most sensitive, reacting with 100% of MFSS and 92% of PDSS, followed by cytokeratin AE1/AE3 (70% of MFSS, 46% of PDSS), cytokeratin KL1 (49% of MFSS, 38% of PDSS), and E-cadherin (47% of MFSS, 54% of PDSS). A staining for cytokeratin AE1/AE3 and/or E-cadherin was observed in 79% of MFSS and 69% of PDSS, and a staining for cytokeratin KL1 and/or E-cadherin was observed in 74% of MFSS and 62% of PDSS. S-100 protein was positive in 38% of MFSS and 23% of PDSS, and alpha-smooth muscle actin in 21% of MFSS and 8% of PDSS. Tumor cells were rarely positive for CD34 (6% of MFSS, 0% of PDSS) and desmin (2% of MFSS, 0% of PDSS). Most SS were strongly positive for bcl-2 (91% of MFSS, 92% of PDSS) and CD99 (91% of MFSS, 100% of PDSS). A weak and focal cytoplasmic reactivity for CD117 was observed in 11% of MFSS (only one case had a strong immunoreactivity) and 8% of PDSS. Staining with h-caldesmon was consistently negative. In conclusion, in keeping with literature data, our results show that reactivity for epithelial membrane antigen, cytokeratin AE1/AE3, and E-cadherin, in combination with CD34 negativity, are the most useful and sensitive markers for diagnosing monophasic fibrous and poorly differentiated t(X;18)-positive SS. They also support the fact that about one third of MFSS and one fourth of PDSS are positive for S-100 protein, a finding of diagnostic relevance when considering their distinction from other spindle to round cell sarcomas, especially malignant peripheral nerve sheath tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409719     DOI: 10.1097/00000478-200211000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  33 in total

1.  TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas.

Authors:  Leonardo Saúl Lino-Silva; Juan Pablo Flores-Gutiérrez; Natalia Vilches-Cisneros; Hugo Ricardo Domínguez-Malagón
Journal:  Virchows Arch       Date:  2011-11-10       Impact factor: 4.064

Review 2.  Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:  Markku Miettinen
Journal:  Histopathology       Date:  2013-11-28       Impact factor: 5.087

3.  Biphenotypic Sinonasal Sarcoma-Case Report and Review of Clinicopathological Features and Diagnostic Modalities.

Authors:  Chandala Chitguppi; Ian Koszewski; Kaitlin Collura; Mark Curtis; Gurston Nyquist; Mindy Rabinowitz; Marc Rosen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

4.  Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.

Authors:  Lisa M Rooper; Shih-Chiang Huang; Cristina R Antonescu; William H Westra; Justin A Bishop
Journal:  Hum Pathol       Date:  2016-04-29       Impact factor: 3.466

5.  Synovial sarcoma of the chest wall: a case report and literature review.

Authors:  Emna Braham; Slim Aloui; Samira Aouadi; Ikram Drira; Tarek Kilani; Faouzi El Mezni
Journal:  Ann Transl Med       Date:  2013-04

6.  Biphasic synovial sarcoma of the abdominal wall.

Authors:  Jesús Vera; María-Dolores García; Miguel Marigil; Manuel Abascal; Jose-Ignacio Lopez; Luis Ligorred
Journal:  Virchows Arch       Date:  2006-07-20       Impact factor: 4.064

Review 7.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

8.  Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.

Authors:  Torsten O Nielsen; Forrest D Hsu; John X O'Connell; C Blake Gilks; Poul H B Sorensen; Sabine Linn; Robert B West; Chih Long Liu; David Botstein; Patrick O Brown; Matt van de Rijn
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 9.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

Review 10.  The value of immunohistochemistry in diagnosing primary renal synovial sarcoma: a case report and literature review.

Authors:  Luo Yang; Kunjie Wang; Li Hong; Yan Wang; Xiang Li
Journal:  Int Surg       Date:  2012 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.